https://www.nejm.org/doi/full/10.1056/NEJMe2207681
0
0
8/3/22 at 9:04pm
Organization
nejm.org
29 words
0
Comments
Editorial from The New England Journal of Medicine — Monoclonal Antibody Therapy in Parkinson’s Disease — The End?
You are the first to view
Create an account
or login to join the discussion